C. Maier

发表

Nonclinical Models to Assess Respiratory Hypersensitivity Potential

C. Maier, 2008 .

Immunomodulatory Effects of Anti-CD4 Antibody in Host Resistance against Infections and Tumors in Human CD4 Transgenic Mice

P. Bugelski, T. Hart, D. Herzyk, 2001, Infection and Immunity.

J. Blalock, F. Galin, J. Whitaker, 1999, Journal of Neuroimmunology.

Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use

T. Maclachlan, Kathryn L Chapman, J. W. van der Laan, 2017, mAbs.

Biochemical features of anergic T cells

M. Greene, C. Maier, 1998, Immunologic research.

Modulation of Kv Channel Expression and Function by TCR and Costimulatory Signals during Peripheral CD4+ Lymphocyte Differentiation

B. Freedman, B. Fleischmann, L. Turka, 2002, The Journal of experimental medicine.

Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies.

T. Maclachlan, N. Marshall, Shawn J Berens, 2020, Regulatory toxicology and pharmacology : RTP.

Unique molecular surface features of in vivo tolerized T cells.

M. Greene, A. Bhandoola, K. Yui, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Consensus on the Key Characteristics of Immunotoxic Agents as a Basis for Hazard Identification

Andrew A. Rooney, L. Zeise, C. McHale, 2022, Environmental health perspectives.

In vivo biodistribution and pharmacokinetics of sotrovimab, a SARS-CoV-2 monoclonal antibody, in healthy cynomolgus monkeys

Andrew P Mayer, H. Alsaid, S. Lenhard, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA

J. Blalock, B. Marchetti, R. D. Leboeuf, 1992, Cellular and Molecular Neurobiology.

HESI/FDA workshop on immunomodulators and cancer risk assessment: Building blocks for a weight-of-evidence approach.

R. Ponce, H. Lebrec, D. Weinstock, 2016, Regulatory toxicology and pharmacology : RTP.

Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies.

Rafael Ponce, Lakshmi Amaravadi, Gopi Shankar, 2009, Regulatory toxicology and pharmacology : RTP.

Murine V l x and V l x-containing Antibodies Bind Human Myelin Basic Protein

J. Blalock, F. Galin, J. Whitaker, 2013 .

Murine V (cid:108) x and V (cid:108) x-containing Antibodies Bind Human Myelin Basic Protein

J. Blalock, F. Galin, J. Whitaker, 1996 .

Immunopharmacology of recombinant human interleukin-18 in non-human primates.

P. Bugelski, J. Soos, Z. Jonak, 2002, Cytokine.

Derived from the Structure of an Anti-Idiotype Antibody Molecular Mimicry of Carcinoembryonic Antigen by Peptides

J. Blalock, Kenneth, P. Tripathi, 2006 .

Nonclinical safety assessment of engineered T cell therapies.

R. Ponce, H. Lebrec, J. Shenton, 2021, Regulatory toxicology and pharmacology : RTP.

Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.

J. Blalock, K. Foon, P. Tripathi, 1998, Cancer research.

The structure of a myelin basic protein-associated idiotope

J. Blalock, R. D. Leboeuf, J. Whitaker, 1993, Journal of Neuroimmunology.

High-Dose Recombinant Interleukin-18 Induces an Effective Th1 Immune Response to Murine MOPC-315 Plasmacytoma

M. Lotze, K. Johanson, R. Kirkpatrick, 2002, Journal of immunotherapy.

Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses.

L. Donnelly, M. Reed, B. Forbes, 2014, Advanced drug delivery reviews.

Developing a framework for assessing chemical respiratory sensitization: A workshop report.

Janine Ezendam, Ian Kimber, Antti Karjalainen, 2016, Regulatory toxicology and pharmacology : RTP.

Assessing a theoretical risk of dolutegravir-induced developmental immunotoxicity in juvenile rats.

T. Fukushima, M. Rhodes, Susan B Laffan, 2012, Toxicological sciences : an official journal of the Society of Toxicology.

Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation

C. Auffray, D. Piatier‐Tonneau, R. Murali, 1996, Nature Biotechnology.

Murine V lambda x and V lambda x-containing antibodies bind human myelin basic protein.

J. Blalock, F. Galin, J. Whitaker, 1996, The Journal of clinical investigation.

A V lambda x-bearing monoclonal antibody with similar specificity and sequence to encephalitogenic T cell receptors.

J. Blalock, N. Krishna, F. Galin, 1994, Journal of immunology.

Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification.

R. Matico, C. Matheny, A. Malfait, 2015, Osteoarthritis and cartilage.

A cross‐reactive anti‐myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis

J. Blalock, C. Laganke, J. Whitaker, 1998, Neurology.

[22] Cloning and sequencing immunoglobulin and T-cell receptor variable regions involved in neuroimmune disorders

J. Blalock, C. Maier, 1995 .

TITLE : Developing a Framework for Assessing Respiratory Sensitization : A Workshop Report

S. Tarlo, S. Enoch, C. North, 2018 .

Developing a framework for assessing respiratory sensitization: A workshop report

S. Tarlo, S. Enoch, C. North, 2016 .

A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.

J. Blalock, J. Whitaker, C. Maier, 1994, Journal of immunology.

Simultaneous evaluation of treatment efficacy and toxicity for bispecific T‐cell engager therapeutics in a humanized mouse model

J. Keck, D. Greiner, L. Shultz, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses.

L. Donnelly, M. Reed, B. Forbes, 2014, Advanced drug delivery reviews.

Identification of interactive determinants on idiotypic-anti-idiotypic antibodies through comparison of their hydropathic profiles.

H. Moseley, J. Blalock, J. Whitaker, 1994, ImmunoMethods.